Rubertis Francesco De

CNTA

Rubertis Francesco De serves as Director at Centessa Pharmaceuticals plc (CNTA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

4 trades

$14.43M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$14.43M

Companies Traded

CNTA

Active Period

Jan 2021 – Dec 2021

4 total trades

Most Recent

Buy CNTA

Dec 2, 2021 · $440.1K

Rubertis Francesco De's Insider Trading at Centessa Pharmaceuticals plc (CNTA)

Buys

4 · $14.43M

Sells

0 · $0.00

Total Shares Bought

800,000

Total Shares Sold

CNTA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Dec 2, 2021	Buy	34,326	$12.82	$440.1K
Nov 30, 2021	Buy	97,151	$12.24	$1.19M
Nov 26, 2021	Buy	68,523	$11.64	$797.4K
Jan 29, 2021	Buy	600,000	$20.00	$12.00M

Related Insiders

Mario Alberto Accardi

President, Orexin Program

CNTASell · Feb 1, 2026

Karen M. Anderson

Chief People Officer

CNTASell · Feb 1, 2026

Tia L Bush

Chief Technology & Quality Ofc

CNTASell · Feb 1, 2026

Gregory M Weinhoff

Chief Business Officer

CNTASell · Feb 1, 2026

HUSSAIN IQBAL J

General Counsel

CNTASell · Jan 30, 2026

Explore More Insider Trading Data

CNTA Insider Trading Activity

View all insider trades at Centessa Pharmaceuticals plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity